A5044757810- Tuberculosis Research and Epidemiology
- Antifungal resistance and susceptibility
- Pharmaceutical studies and practices
- Infectious Diseases and Tuberculosis
- Mycobacterium research and diagnosis
- Diagnosis and treatment of tuberculosis
- Venous Thromboembolism Diagnosis and Management
- HIV/AIDS drug development and treatment
- HIV Research and Treatment
- Viral Infections and Vectors
- Pharmacological Effects and Toxicity Studies
- Antibiotics Pharmacokinetics and Efficacy
- Infective Endocarditis Diagnosis and Management
- Central Venous Catheters and Hemodialysis
- Clostridium difficile and Clostridium perfringens research
- Pain Mechanisms and Treatments
- Sinusitis and nasal conditions
- HIV/AIDS Research and Interventions
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Hematological disorders and diagnostics
- Mosquito-borne diseases and control
- Pneumonia and Respiratory Infections
- Psoriasis: Treatment and Pathogenesis
- Foreign Body Medical Cases
- Zoonotic diseases and public health
Centers for Disease Control and Prevention
2024
Eli Lilly (United States)
2020
Olive View-UCLA Medical Center
2015-2016
University of California, Los Angeles
2006-2015
Washington State Department of Health
2013
Salford Royal NHS Foundation Trust
2012
UCLA Medical Center
2006-2008
The Lundquist Institute
2008
Harbor–UCLA Medical Center
2006-2007
Los Angeles Medical Center
2006
It has been axiomatic that echinocandins (e.g., caspofungin) are ineffective against mucormycosis. However, on the basis of preclinical data, we recently began treating rhino-orbital-cerebral mucormycosis (ROCM) with combination polyene-caspofungin therapy.To determine impact therapy, ROCM cases identified by an International Classification Diseases, Ninth Revision search were retrospectively reviewed to gather data demographic characteristics, clinical history, and outcomes. The predefined...
Abstract Background Rifampin-resistant tuberculosis is a leading cause of morbidity worldwide; only one-third persons start treatment, and outcomes are often inadequate. Several trials demonstrate 90% efficacy using an all-oral, 6-month regimen bedaquiline, pretomanid, linezolid (BPaL), but significant toxicity occurred 1200-mg linezolid. After US Food Drug Administration approval in 2019, some clinicians rapidly implemented BPaL initial 600-mg dose adjusted by serum drug concentrations...
Arthropod-borne viruses (arboviruses) threaten the health of humans, livestock, and wildlife. West Nile virus (WNV), world's most widespread arbovirus, invaded United States in 1999 rapidly spread across county. Although ecology vectors hosts are key determinants WNV prevalence landscapes, factors shaping local vector host populations remain unclear. Here, we used spatially-explicit models to evaluate how three land-use types (orchards, vegetable/forage crops, natural) two climatic variables...
For decades, multiple public health and clinical tools have been used to prevent tuberculosis (TB) transmission.Two of these are directly discussed in the document by National Tuberculosis Coalition America (NTCA) this issue Clinical Infectious Diseases: (1) prompt effective TB disease treatment (2) isolation, or separating persons with from others until non-infectious.Use nucleic acid amplification tests can facilitate rapid diagnosis, detection drug resistance, early [1,2]; initiation is...